Posted by Michael Wonder on 14 Aug 2019
The window for Congress to do something on drug prices won’t be open forever
14 August 2019 - It’s do-or-die time on drug pricing when Congress returns to Washington in a few weeks.
That’s how stakeholders are viewing the whole messy effort to take major action to lower the high prices of prescription medicines in the United States — a top-polling worry among voters that President Trump has repeatedly promised to tackle.
If lawmakers don’t find a bipartisan way forward this fall, prospects for anything substantial happening will fade as the 2020 election ramps up and Democrats become even less willing to play ball.
